At time of writing there is no standardised treatment for alleviation of breathlessness (dyspnea), which is one of the most commonly reported symptom of Long COVID.
There is a great need to provide a treatment to alleviate dyspnea in the population - both to improve their quality of life and reduce sedentary time caused by post exertional malaise (PEM).
Some studies have identified clinically meaningful outcomes from inspiratory muscle training. However, there is a lack of consistent and reproducible evidence. Therefore research is needed to replicate these findings to potentially change policy.